# Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome

> **NCT04718025** · PHASE3 · UNKNOWN · sponsor: **Collegium Medicum w Bydgoszczy** · enrollment: 4500 (estimated)

## Conditions studied

- STEMI
- NSTEMI
- Unstable Angina

## Interventions

- **DRUG:** Ticagrelor 90mg
- **DRUG:** Ticagrelor 60mg
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT04718025
- **Lead sponsor:** Collegium Medicum w Bydgoszczy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-07
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 4500 (ESTIMATED)
- **Last updated:** 2023-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04718025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04718025, "Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04718025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*